Ticker: ANGO

AngioDynamics, Inc. (NASDAQ: ANGO) - Quick corporate snapshot * Reporting period: three months ended August 31, 2025 (Form 10‑Q). * Business: diversified medical technology (two segments: Med Tech and Med Device). Key financials (three months ended Aug 31, 2025 vs Aug 31, 2024) * Net sales: $75,7...

Company Overview: AngioDynamics (NASDAQ: ANGO) is a medical technology company focused on vascular access, oncology, and the treatment of peripheral vascular disease. The company's portfolio includes products for minimally invasive procedures aimed at improving patient outcomes and quality of lif...